443 related articles for article (PubMed ID: 31096567)
21. Immunotherapy in ovarian, endometrial and cervical cancer: State of the art and future perspectives.
Ventriglia J; Paciolla I; Pisano C; Cecere SC; Di Napoli M; Tambaro R; Califano D; Losito S; Scognamiglio G; Setola SV; Arenare L; Pignata S; Della Pepa C
Cancer Treat Rev; 2017 Sep; 59():109-116. PubMed ID: 28800469
[TBL] [Abstract][Full Text] [Related]
22. Targeting Stromal-Cancer Cell Crosstalk Networks in Ovarian Cancer Treatment.
Yeung TL; Leung CS; Li F; Wong SS; Mok SC
Biomolecules; 2016 Jan; 6(1):3. PubMed ID: 26751490
[TBL] [Abstract][Full Text] [Related]
23. The immunohistochemical analysis of antigens such as RCAS1 and B7H4 in the cervical cancer nest and within the fibroblasts and macrophages infiltrating the cancer microenvironment.
Galazka K; Opławski M; Windorbska W; Skret-Magierlo J; Koper K; Basta P; Mach P; Dutch-Wicherek M; Mazur A; Wicherek L
Am J Reprod Immunol; 2012 Jul; 68(1):85-93. PubMed ID: 22530960
[TBL] [Abstract][Full Text] [Related]
24. Dynamics of T-cell infiltration during the course of ovarian cancer: the gradual shift from a Th17 effector cell response to a predominant infiltration by regulatory T-cells.
Fialová A; Partlová S; Sojka L; Hromádková H; Brtnický T; Fučíková J; Kocián P; Rob L; Bartůňková J; Spíšek R
Int J Cancer; 2013 Mar; 132(5):1070-9. PubMed ID: 22865582
[TBL] [Abstract][Full Text] [Related]
25. Immune control in hepatocellular carcinoma development and progression: role of stromal cells.
Sprinzl MF; Galle PR
Semin Liver Dis; 2014 Nov; 34(4):376-88. PubMed ID: 25369300
[TBL] [Abstract][Full Text] [Related]
26. The Immune Microenvironment in Human Papilloma Virus-Induced Cervical Lesions-Evidence for Estrogen as an Immunomodulator.
R S J
Front Cell Infect Microbiol; 2021; 11():649815. PubMed ID: 33996630
[TBL] [Abstract][Full Text] [Related]
27. Immunosuppressive cells and tumour microenvironment: focus on mesenchymal stem cells and myeloid derived suppressor cells.
Bianchi G; Borgonovo G; Pistoia V; Raffaghello L
Histol Histopathol; 2011 Jul; 26(7):941-51. PubMed ID: 21630223
[TBL] [Abstract][Full Text] [Related]
28. Tumor microenvironment and metabolism in prostate cancer.
Chiarugi P; Paoli P; Cirri P
Semin Oncol; 2014 Apr; 41(2):267-80. PubMed ID: 24787298
[TBL] [Abstract][Full Text] [Related]
29. Activation of a positive feedback loop involving IL-6 and aromatase promotes intratumoral 17β-estradiol biosynthesis in endometrial carcinoma microenvironment.
Che Q; Liu BY; Liao Y; Zhang HJ; Yang TT; He YY; Xia YH; Lu W; He XY; Chen Z; Wang FY; Wan XP
Int J Cancer; 2014 Jul; 135(2):282-94. PubMed ID: 24347287
[TBL] [Abstract][Full Text] [Related]
30. PDGF-AA mediates mesenchymal stromal cell chemotaxis to the head and neck squamous cell carcinoma tumor microenvironment.
Watts TL; Cui R; Szaniszlo P; Resto VA; Powell DW; Pinchuk IV
J Transl Med; 2016 Dec; 14(1):337. PubMed ID: 27931212
[TBL] [Abstract][Full Text] [Related]
31. Chemokines mRNA expression in relation to the Macrophage Migration Inhibitory Factor (MIF) mRNA and Vascular Endothelial Growth Factor (VEGF) mRNA expression in the microenvironment of endometrial cancer tissue and normal endometrium: a pilot study.
Giannice R; Erreni M; Allavena P; Buscaglia M; Tozzi R
Cytokine; 2013 Nov; 64(2):509-15. PubMed ID: 23985752
[TBL] [Abstract][Full Text] [Related]
32. Tumor-associated stromal cells as key contributors to the tumor microenvironment.
Bussard KM; Mutkus L; Stumpf K; Gomez-Manzano C; Marini FC
Breast Cancer Res; 2016 Aug; 18(1):84. PubMed ID: 27515302
[TBL] [Abstract][Full Text] [Related]
33. The Immune Landscape in Women Cancers.
Timperi E; Vissio E; Marchiò C; Romano E
Cancer Treat Res; 2020; 180():215-249. PubMed ID: 32215872
[TBL] [Abstract][Full Text] [Related]
34. Estrogens, Estrogen Receptors and Tumor Microenvironment in Ovarian Cancer.
Kozieł MJ; Piastowska-Ciesielska AW
Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834120
[TBL] [Abstract][Full Text] [Related]
35. The chemokine growth-regulated oncogene 1 (Gro-1) links RAS signaling to the senescence of stromal fibroblasts and ovarian tumorigenesis.
Yang G; Rosen DG; Zhang Z; Bast RC; Mills GB; Colacino JA; Mercado-Uribe I; Liu J
Proc Natl Acad Sci U S A; 2006 Oct; 103(44):16472-7. PubMed ID: 17060621
[TBL] [Abstract][Full Text] [Related]
36. Single-cell dissection of cellular components and interactions shaping the tumor immune phenotypes in ovarian cancer.
Hornburg M; Desbois M; Lu S; Guan Y; Lo AA; Kaufman S; Elrod A; Lotstein A; DesRochers TM; Munoz-Rodriguez JL; Wang X; Giltnane J; Mayba O; Turley SJ; Bourgon R; Daemen A; Wang Y
Cancer Cell; 2021 Jul; 39(7):928-944.e6. PubMed ID: 33961783
[TBL] [Abstract][Full Text] [Related]
37. Implications of NOVA1 suppression within the microenvironment of gastric cancer: association with immune cell dysregulation.
Kim EK; Yoon SO; Jung WY; Lee H; Kang Y; Jang YJ; Hong SW; Choi SH; Yang WI
Gastric Cancer; 2017 May; 20(3):438-447. PubMed ID: 27318497
[TBL] [Abstract][Full Text] [Related]
38. Comprehensive analysis of intratumoral lymphocytes and FOXP3 expression in tumor cells of endometrial cancer.
Iurchenko NP; Glushchenko NM; Buchynska LG
Exp Oncol; 2014 Dec; 36(4):262-6. PubMed ID: 25537221
[TBL] [Abstract][Full Text] [Related]
39. Microenvironment remodeled by tumor and stromal cells elevates fibroblast-derived COL1A1 and facilitates ovarian cancer metastasis.
Li M; Wang J; Wang C; Xia L; Xu J; Xie X; Lu W
Exp Cell Res; 2020 Sep; 394(1):112153. PubMed ID: 32589888
[TBL] [Abstract][Full Text] [Related]
40. B7-H4 overexpression impairs the immune response of T cells in human cervical carcinomas.
Wang X; Wang T; Xu M; Xiao L; Luo Y; Huang W; Zhang Y; Geng W
Hum Immunol; 2014 Dec; 75(12):1203-9. PubMed ID: 25446402
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
